Uncategorized

TearScience announces 50% price reduction in LipiFlow activators

by Healio ophthalmology • 2015/10/26 • 0 Comments

NEW YORK — LipiFlow single-use activators will soon cost much less.At OSN New York, Joseph Boorady, president and CEO of TearScience, announced that the company will be lowering the cost of its LipiFlow single-use activators by 50% on Nov. 2.

Full Story →

← Ophthotech Completes Patient Recruitment of the Second Phase 3 Pivotal Trial of Fovista® Anti-PDGF Therapy in Combination with Lucentis® in Wet Age-Related Macular Degeneration

Wen: The Doctor Is (Not?) Listening →

Post navigation